Press release
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases.The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs.
Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/2811?utm_source=openpr_ss
However, the side effects of migraine medications are expected to limit market growth. On the contrary, it is expected that new emerging therapies / medications for the treatment of migraine and growth opportunities in emerging countries present opportunities for market growth during the forecast period.
By type, abortifacient drugs accounted for more than three quarters of the global market for migraine drugs in 2017. In addition, by administration, the oral segment is expected to grow at the highest rate of 3.4% during the forecast period.
Send Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/2811?utm_source=openpr_ss
Key Market Players:
• Abbott Laboratories
• Allergan Plc.
• AstraZeneca
• Eisai Co. Ltd.
• Endo International Plc.
• GlaxoSmithKline Plc.
• Impax Laboratories
Key Findings of Migraine Drugs Market:
•North America occupied the two-fifths of the world market for migraine medicines.
•It is anticipated that Oral will grow with the highest CAGR throughout the forecast period.
•It is expected that Europe will occupy more than a quarter of the market share of the global market for migraine drugs by 2025.
•It is anticipated that Asia-Pacific will grow at the highest rate during the analysis period, followed by LAMEA.
Browse More Information of Report @ https://www.alliedmarketresearch.com/press-release/migraine-drugs-market.html
About Us:
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025 here
News-ID: 1577855 • Views: …
More Releases from Allied Market Research
Outdoor Decor Market 2026 : to Reach USD 117.7 Billion by 2032 Top Impacting Fac …
llied Market Research published a report, titled, "Outdoor Décor Market by product (Furniture, Flower Pots and Planters, Rugs and Cushions, Lighting, Patio Umbrellas and Shade Structures, Water Features and Others), End User (Residential and Non-residential), and Distribution Channel (Supermarket and hypermarket, Specialty Stores, E-Commerce and Others): Global Opportunity Analysis and Industry Forecast, 2022-2032". According to the report, the global outdoor decor market size was valued at $83 billion in 2022,…
USD 1.03 Billion GCC Sanitary Ware Market Value Cross by 2032 | Top Players such …
Allied Market Research published a report, titled, "GCC Sanitary Ware Market by Material (Ceramics, Pressed Metals, Acrylic Plastics and Perspex, and Others), by Product Type (Toilet Sink/Water Closet, Wash Basin, Pedestal, and Cistern), By End User (Residential, Commercial, and Others), By Application (Bathroom and Kitchen), By Price Range (Up To $200, $201 To $500, and $500 and above)". According to the report, the GCC sanitary ware market was valued at…
Metallized PET Packaging Market is Projected to Grow Expeditiously: USD 9.8 Bill …
Allied Market Research has recently published a report, titled, "Metallized PET Packaging Market Size, Share, Competitive Landscape and Trend Analysis Report by Type, by Application: Global Opportunity Analysis and Industry Forecast, 2023-2032." According to the report, the global metallized pet packaging market size was valued at $6 billion in 2022, and is projected to reach $9.8 billion by 2032, growing at a CAGR of 5.1% from 2023 to 2032.
Download…
Pre-Engineered Buildings Industry Poised for Strong Expansion by 2032 on Back of …
Allied Market Research published a report, titled, "Pre-Engineered Buildings Market by Structure (Single-story and Multi-story), and Application (Commercial, Industrial): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global pre-engineered buildings market size was valued at $17.6 million in 2022, and is projected to reach $46.6 million by 2032, registering a CAGR of 10.4% from 2023 to 2032.
Request PDF Sample Copy @https://www.alliedmarketresearch.com/request-sample/3178
Prime determinants of growth
The expansion of…
More Releases for Migraine
Leading Growth Driver in the Migraine Market Share in 2025: Rising Prevalence Of …
What Market Share dynamics are playing a key role in accelerating the growth of the migraine Market Share?
The migraine Market Share is projected to grow, driven by the rising occurrence of migraines. Migraines, a kind of headache that typically affects one side of the brain and causes intense, throbbing pain or a pulsing sensation, can be managed and relief can be provided via proper treatment. This treatment paves the way…
Emerging Acute Migraine Treatment Market Trend 2025-2034: Innovative CGRP Recept …
How Is the Acute Migraine Treatment Market Projected to Grow, and What Is Its Market Size?
The market size for acute migraine treatment has witnessed substantial growth in the past few years. Forecasts expect it to expand from $2.6 billion in 2024 to $2.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the historical period include the rising incidence of migraines,…
Key Influencer in the Migraine Market 2025: Rising Prevalence Of Migraine Drives …
"What Is the Forecasted Market Size and Growth Rate for the Migraine Market?
The migraine market is projected to grow steadily from $1.93 billion in 2024 to $1.97 billion in 2025, at a CAGR of 2.2%. This growth is attributed to the rising prevalence of migraines, growing awareness of treatment options, government initiatives, increased alcohol consumption, and lifestyle changes.
Migraine Market: Expected to grow to $2.25 billion by 2029 at a CAGR…
How Big is Migraine Drugs Market?
In 2022, the Global Migraine Drugs Market soared to USD 10,972.1 million, marking a significant milestone. Projections indicate a promising trajectory, with expectations set for substantial growth, potentially reaching USD 26,618.96 million by 2031. Forecasts for the period between 2024 and 2031 suggest a robust Compound Annual Growth Rate (CAGR) of 12.1% for the migraine drugs market.
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive…
Migraine Therapeutics Market - Relieve the Burden: Empowering Lives through Migr …
Newark, New Castle, USA - new report, titled Migraine Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Migraine Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Migraine Therapeutics market. The report offers an overview of the market, which…
Increasing incidences of migraine sufferers driving the Anti-Migraine Drugs Mark …
Antimigraine drugs are the therapeutic agents indicated to use against migraine headaches. Migraine is characterized by recurrent attacks of moderate to severe headaches along with other nervous system symptoms. Migraine is more common in women than men, majorly due to the fluctuations in the harmone levels. According to a Medline article, around 12% of the U.S. population suffers from migraine headaches. The two major types of migraine are classic and…
